BioAge seeks nearly $200 million in initial public offering
September 27, 2024 at 07:06 AM EDT
The company is concentrating its aging diseases focus on weight loss and diabetes control.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|